ATE262316T1 - Herstellungsverfahren für carotenoid- zusammensetzungen - Google Patents

Herstellungsverfahren für carotenoid- zusammensetzungen

Info

Publication number
ATE262316T1
ATE262316T1 AT97106957T AT97106957T ATE262316T1 AT E262316 T1 ATE262316 T1 AT E262316T1 AT 97106957 T AT97106957 T AT 97106957T AT 97106957 T AT97106957 T AT 97106957T AT E262316 T1 ATE262316 T1 AT E262316T1
Authority
AT
Austria
Prior art keywords
carotenoid
production process
carotenoid compositions
disclosed
emulsion
Prior art date
Application number
AT97106957T
Other languages
German (de)
English (en)
Inventor
Ray Edward Kowalski
William Joseph Mergens
Leonard Joseph Scialpi
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE262316T1 publication Critical patent/ATE262316T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/924Significant dispersive or manipulative operation or step in making or stabilizing colloid system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT97106957T 1996-05-14 1997-04-26 Herstellungsverfahren für carotenoid- zusammensetzungen ATE262316T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1756896P 1996-05-14 1996-05-14

Publications (1)

Publication Number Publication Date
ATE262316T1 true ATE262316T1 (de) 2004-04-15

Family

ID=21783319

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97106957T ATE262316T1 (de) 1996-05-14 1997-04-26 Herstellungsverfahren für carotenoid- zusammensetzungen

Country Status (10)

Country Link
US (1) US6093348A (forum.php)
EP (1) EP0807431B1 (forum.php)
JP (1) JP3961070B2 (forum.php)
CN (1) CN1079212C (forum.php)
AT (1) ATE262316T1 (forum.php)
BR (1) BR9703134A (forum.php)
DE (1) DE69728206T2 (forum.php)
DK (1) DK0807431T3 (forum.php)
ES (1) ES2216079T3 (forum.php)
IN (1) IN183685B (forum.php)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0876109T3 (da) * 1996-01-22 2003-10-20 Chr Hansen As Flydende farvegivende middel
KR20010073232A (ko) 1998-11-20 2001-07-31 추후제출 분산성 인지질로 안정화된 마이크로입자
CA2407027C (en) * 2000-04-20 2011-02-15 Rtp Pharma Inc. Improved water-insoluble drug particle process
US20030104090A1 (en) * 2000-05-05 2003-06-05 Levy Pedro E. Supplements containing annatto extracts and carotenoids and methods for using the same
ATE367802T1 (de) 2000-09-20 2007-08-15 Jagotec Ag Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
DE10064387A1 (de) * 2000-12-21 2002-06-27 Basf Ag Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Sauerstoff-haltiger Carotinoide
US7064101B2 (en) 2001-03-22 2006-06-20 Fuji Chemical Industry Co., Ltd. Stable astaxanthin-containing powdery compositions and process for producing the same
US6811801B2 (en) * 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
EP2823809B1 (en) * 2002-06-28 2016-11-02 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
WO2004011423A2 (en) * 2002-07-29 2004-02-05 Hawaii Biotech, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
CN1764439B (zh) * 2003-03-27 2010-05-26 帝斯曼知识产权资产管理有限公司 制备交联明胶珠粒的方法
US7110827B2 (en) * 2003-04-25 2006-09-19 Medtronic, Inc. Electrical connectors for medical lead having weld-less wiring connection
US7332178B2 (en) 2003-04-25 2008-02-19 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
CA2564066A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
JP4562174B2 (ja) * 2004-08-23 2010-10-13 カゴメ株式会社 カロテノイド含有物の製造方法
AU2005279201B2 (en) * 2004-08-31 2011-08-04 Akzo Nobel N.V. Method for pigment solubilisation, a pigment composition and its use
US10463061B2 (en) * 2004-11-19 2019-11-05 Dsm Ip Assets B.V. Modified plant gums for preparations of active ingredients
US8755258B2 (en) 2005-02-16 2014-06-17 Mitsubishi Electric Corporation Optical disc and optical disc device
CN100421650C (zh) * 2005-03-23 2008-10-01 浙江新和成股份有限公司 水分散性类胡萝卜素粉的制备方法
EP1937213B1 (en) * 2005-07-27 2017-10-25 Protiva Biotherapeutics Inc. Systems and methods for manufacturing liposomes
CN101243032B (zh) * 2005-08-15 2012-10-10 法雷斯药品研究公司 虾青素的晶型
US7435846B2 (en) * 2006-08-18 2008-10-14 Industrial Organica, S.A. De C.V. Absorption and bioavailability of carotenoids, formulations and applications
NZ579082A (en) * 2007-03-15 2012-10-26 Dsm Ip Assets Bv Stable suspensions of micronised particles of a solid organic compound which is free of surfactants, thickeners, poly-electrolytes or block copolymers
WO2009093595A1 (ja) * 2008-01-25 2009-07-30 Fujifilm Corporation カロテノイド含有エマルション組成物の製造方法、それにより得られるカロテノイド含有エマルション組成物並びにカロテノイド含有粉末組成物、該組成物を含む機能性食品及び化粧品
EP2210593A3 (en) 2009-01-21 2011-05-18 DSM IP Assets B.V. Tablettable formulations of vitamin A and derivatives thereof
US9724664B2 (en) 2009-03-27 2017-08-08 Bend Research, Inc. Spray-drying process
AU2010293447B2 (en) 2009-09-14 2013-07-04 National University Corporation Hokkaido University Anti-plant-virus agent
CN102933098B (zh) * 2010-06-08 2017-03-29 三荣源有限公司 防止类胡萝卜色素附着于容器的方法
JP5600513B2 (ja) * 2010-07-29 2014-10-01 理研ビタミン株式会社 クロセチン製剤の製造方法
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
EP2611530B1 (en) 2010-09-03 2019-01-16 Bend Research, Inc. Spray-drying apparatus and methods of using the same
EP2618924A1 (en) 2010-09-24 2013-07-31 Bend Research, Inc. High-temperature spray drying process and apparatus
US20130317098A1 (en) * 2010-11-26 2013-11-28 Christian Schaefer Protective hydrocolloid for active ingredients
US20120157547A1 (en) 2010-12-21 2012-06-21 Ricardo Montoya-Olvera Compositions and applications of carotenoids of improved absorption and bioavailability
CN104736229B (zh) * 2012-10-18 2017-05-03 帝斯曼知识产权资产管理有限公司 包含类胡萝卜素的珠粒
WO2015044222A1 (en) * 2013-09-24 2015-04-02 Dsm Ip Assets B.V. Stable formulations for coloring beverages and food products
PT3212169T (pt) 2014-10-31 2021-05-06 Bend Res Inc Processo para formar domínios ativos dispersos numa matriz
US11744266B2 (en) 2016-03-15 2023-09-05 Dsm Ip Assets B.V. Coated particles
JP6954917B2 (ja) * 2016-03-24 2021-10-27 ビーエイエスエフ・ソシエタス・エウロパエアBasf Se 多相活性物質調製物
WO2018015346A1 (de) * 2016-07-19 2018-01-25 Basf Se Propylgallathaltige vitaminzubereitungen
US11197493B2 (en) * 2017-09-12 2021-12-14 Omniactive Health Technologies Limited Stabilized fat soluble nutrient compositions and process for the preparation thereof
JP7225820B2 (ja) 2019-01-21 2023-02-21 株式会社アイシン 車両用開閉体制御装置
BR112021025185A2 (pt) * 2019-06-17 2022-02-01 Dsm Ip Assets Bv Forma de dosagem farmacêutica compreendendo metformina e citrato de cálcio
BR112021025180A2 (pt) * 2019-06-17 2022-02-01 Dsm Ip Assets Bv Forma de dosagem farmacêutica sólida compreendendo vitamina b12 seca por pulverização
BR112021025200A2 (pt) * 2019-06-17 2022-02-01 Dsm Ip Assets Bv Composição compreendendo metformina hcl, vitamina b12 e pelo menos um aditivo de fluxo
CN112438950A (zh) * 2019-08-16 2021-03-05 北京化工大学 一种β-胡萝卜素透明水分散液及其制备方法
CN111471317B (zh) * 2020-03-26 2021-06-04 广东省农业科学院蚕业与农产品加工研究所 一种稳态化玉米黄色素及其制备方法
CN111838648B (zh) * 2020-06-16 2023-04-25 嘉必优生物技术(武汉)股份有限公司 一种生产纳米级类胡萝卜素乳液的装置及方法
AU2021308681A1 (en) 2020-07-16 2023-03-09 Acuitas Therapeutics, Inc. Cationic lipids for use in lipid nanoparticles
CN112841645A (zh) * 2021-01-14 2021-05-28 江南大学 一种β-胡萝卜素微胶囊的制备方法
CN113426355A (zh) * 2021-06-25 2021-09-24 骏马化纤股份有限公司 一种化纤生产用油剂乳液自动化控制系统及制备方法
WO2023114943A2 (en) 2021-12-16 2023-06-22 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
CN118525919A (zh) * 2023-02-22 2024-08-23 浙江可明生物医药有限公司 类胡萝卜素制剂的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756177A (en) * 1953-03-09 1956-07-24 Hoffmann La Roche Process for making fat-soluble vitamin active powder
US2861891A (en) * 1956-12-13 1958-11-25 Hoffmann La Roche Water dispersible carotenoid compositions and process of making the same
DE1211911B (de) * 1959-09-08 1966-03-03 Hoffmann La Roche Verfahren zur Herstellung eines insbesondere zum Faerben von Lebens- und Futtermitteln geeigneten Carotinoidpraeparates
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
DE3048000A1 (de) * 1980-12-19 1982-07-15 Basf Ag Stabile injizierbare (beta)-carotin-solubilisate und verfahren zu ihrer herstellung
US4533254A (en) * 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4908154A (en) * 1981-04-17 1990-03-13 Biotechnology Development Corporation Method of forming a microemulsion
DE3119383A1 (de) * 1981-05-15 1982-12-02 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
DE3702031A1 (de) * 1987-01-24 1988-08-04 Basf Ag Verfahren zur herstellung von mikrodispersen fischoelpraeparaten
DK0410236T3 (da) * 1989-07-25 1993-12-13 Hoffmann La Roche Fremgangsmåde til fremstilling af caratenoidpræparater
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
DK19393D0 (da) * 1993-02-19 1993-02-19 Danochemo As Fremgangsmaade til fremstilling af et i vand dispergerbart pulverformigt carotenoidpraeparat
DE4329446A1 (de) * 1993-09-01 1995-03-02 Basf Ag Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen
DE19649062A1 (de) * 1996-11-27 1998-05-28 Basf Ag Flüssige, mit Öl mischbare Carotinoid-Zubereitungen

Also Published As

Publication number Publication date
EP0807431A3 (en) 1998-08-12
DK0807431T3 (da) 2004-07-26
JPH1046041A (ja) 1998-02-17
DE69728206D1 (de) 2004-04-29
CN1079212C (zh) 2002-02-20
EP0807431A2 (en) 1997-11-19
BR9703134A (pt) 1998-08-18
EP0807431B1 (en) 2004-03-24
US6093348A (en) 2000-07-25
JP3961070B2 (ja) 2007-08-15
ES2216079T3 (es) 2004-10-16
CN1176760A (zh) 1998-03-25
IN183685B (forum.php) 2000-03-18
DE69728206T2 (de) 2005-03-10

Similar Documents

Publication Publication Date Title
ATE262316T1 (de) Herstellungsverfahren für carotenoid- zusammensetzungen
TW367363B (en) Production of anionic surfactant granules
DE69802538D1 (de) Verfahren zur herstellung einer hochkonzentrierten kolloidalen kieselsäure-suspension und des dabei hergestellten produktes
ATE227980T1 (de) Zubereitung mit verzögerter freisetzung und deren herstellung
ATE178321T1 (de) Verfahren zur herstellung von n-beta-g(b)- hydroxyalkyl-tri-n-carboxyalkyl-1,4,7,10- tetraazacyclododecan- und n-beta-g(b)- hydroxyalkyl-tri-n-carboxyalkyl-1,4,8,11- tetraazacyclotetradecan-derivaten und deren metallkomplexe
NO177828C (no) Vandig papirbeleggsammensetning og fremstilling av papir
CA2347360A1 (en) High-amylose starch-emulsifier composition and methods of making
ATE4293T1 (de) Verfahren zur herstellung von achsen.
PT1025083E (pt) Processo para a sintese estereo-selectiva de derivados da prostaciclina
DE3680490D1 (de) Verfahren zur herstellung von papierprodukten.
ATE65779T1 (de) Verfahren zur herstellung von carbinolderivaten.
WO2002053598A3 (en) Manufacturing process for porous material
WO1995028513A3 (en) Improvements relating to making fiberballs
DE3574583D1 (de) 1,2,3,4,4a,5,8,8a-octahydro-2,2,6,8-tetramethyl-1-naphthalenol, seine anwendung als riechstoff und sein herstellungsverfahren.
GB8622541D0 (en) Producing mouldings
PL367221A1 (en) Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate
DE2964123D1 (en) Process for hydrogenation of 2,6,6-trimethyl cyclohexene derivatives, products produced thereby and organoleptic uses of said products
ATE201619T1 (de) Verfahren und werkzeug zum herstellen von flachlagerschalen
HU896017D0 (en) Process for waterproofing of cement products
EP0808944A3 (de) Herstellung von thermoformbaren Bauteilen
HUT77015A (hu) Foszforral módosított epoxigyanták, eljárás előállításukra, alkalmazásuk és termékek
ATE113806T1 (de) Medaillon und verfahren zum herstellen von medaillonhälften.
KE3302A (en) 3,1-benzoxazine-2-one derivative and process for the production of bromhexin
FR2811932B1 (fr) Procede de fabrication d'un soufflet
AU2002227312A1 (en) Method for making an air filter

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties